Lobar or sublobar resections are safe procedures for management of early lung cancer

Despite the advancement in chemotherapy, radiotherapy, and biological therapy, surgery still remains the best treatment with curative intent for early stage non-small cell lung cancer (NSCLC). Among the different type of resections, lobectomy with radical lymph node resections is the strategy of choice, when anatomically and clinically feasible, based on the results of the randomized controlled trial (RCT) from the Lung Cancer Study Group (LCSG) (1).